Operational Implementation of CAR-T Cell Therapy
Join Niesha Griffith, RPh of McGivney Global Advisors for an online discussion on Tuesday, July 17th at 11:30AM ET with Julie Kennerly-Shah, Pharm D and Alexandra Shillingburg, PharmD on the operational implementation of CAR-T Cell therapy.
Topics which will be covered during the free webinar include:
- The debate over the viability and practicality of CAR-T Therapy provided in the community setting
- Management issues in the operation of a CAR-T Therapy facility
- Payer management from coverage to Centers of Excellence
- Webinar attendee issues and questions
Niesha Griffith, RPh, is an Advising Partner at McGivney Global Advisors, and is nationally recognized for her expertise regarding all aspects of Clinical Pharmacy in Oncology and Cancer Line Services. Ms. Griffith recently served as Vice President, Cancer Services, West Virginia University Health System. Prior to WVU, she spent 19 years of her career at The Ohio State University Medical Center, with the majority of that time spent at The James Comprehensive Cancer Center. Ms. Griffith served in various leadership positions at the James, the last being the Administrator for Oncology Pharmacy and Infusion Services. Ms. Griffith is a past president of the Hematology/Oncology Pharmacy Association (HOPA), where she previously served as Health Policy Chair and Board Member at Large. Ms. Griffith also is a Fellow of the American Society of Health-System Pharmacists (ASHP) and a member of the Advisory Board of the Institute for Clinical Immuno-Oncology of the ACCC.
Dr. Julie Kennerly-Shah, PharmD, MS, MHA, BCPS is an assistant director in the Department of Pharmacy at the Ohio State University and is responsible for hematology/oncology, pain/palliative and ambulatory care clinical services in The James Cancer Hospital. She earned her Doctor of Pharmacy from the University of North Carolina at Chapel Hill and earned dual master degrees from The Ohio State University in the areas of health system pharmacy administration and health care administration. She completed a combined PGY1 and PGY2 Health System Pharmacy Administration Residency at The Ohio State University Wexner Medical Center and completed the Oncology Administration Fellowship at The James Cancer Hospital.
Dr. Alex Shillingburg, PharmD, BCOP is a Clinical Pharmacist Coordinator at the Levine Cancer Institute in Charlotte, NC and has practiced in the specialized area of hematopoietic cell transplantation for 6 years. She has experience in daily clinical care of patients with leukemia, lymphoma, and plasma cell disorders, academics, training post-graduate residents, and organizational policies relating to cellular therapy. Alex obtained her Doctorate in Pharmacy from West Virginia University, is Board Certified in Oncology Pharmacy, and has several medical publications in the field.